Creating a center for analyzing cancer-related proteins and genes
Michigan Center for Translational Cancer Proteogenomics
This study is setting up a special center at the University of Michigan to combine protein and gene information about cancer, helping doctors find better ways to treat patients by discovering important markers that show how cancer grows.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11086800 on NIH RePORTER |
What this research studies
This research establishes a Proteogenomic Data Analysis Center at the University of Michigan, focusing on the integration of proteomics and cancer genomics to enhance precision oncology. The center will utilize advanced algorithms and computational tools to analyze cancer data, aiming to identify key biological markers that drive cancer progression. By collaborating with other institutions, the center will conduct both broad cohort studies and personalized investigations tailored to individual patients. This approach seeks to improve our understanding of cancer biology and the effectiveness of treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients diagnosed with various types of cancer who are seeking personalized treatment options.
Not a fit: Patients with non-cancerous conditions or those not interested in precision oncology approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments based on individual proteogenomic profiles.
How similar studies have performed: Previous research in proteogenomics has shown promise in improving cancer treatment outcomes, indicating that this approach has the potential for significant advancements.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Nesvizhskii, Alexey I — University of Michigan at Ann Arbor
- Study coordinator: Nesvizhskii, Alexey I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.